HeartSciences Depreciation & Amortization Growth & History (HSCS)

HeartSciences's depreciation and amortization was $27,791 for fiscal 2026.

View full HeartSciences company overview

HeartSciences annual depreciation and amortization history

HeartSciences annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20262026-04-30$27,791−$9,808−26.09%
20252025-04-30$37,599$9,707+34.80%
20242024-04-30$27,892$977+3.63%
20232023-04-30$26,915$349+1.31%
20222022-04-30$26,566

HeartSciences depreciation and amortization trends

Between the periods ended 2022-04-30 and 2026-04-30, HeartSciences's depreciation and amortization increased from $26,566 to $27,791, a change of $1,225. The latest reported quarter, Q4 2026, shows $34,002.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review HeartSciences source filings ↗

Community posts

It’s quiet here.

No posts about HSCS yet. Start the conversation.

Write the first post